Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Cash from Investing Activities: 2024-2025

Historic Cash from Investing Activities for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $11.5 million.

  • Pyxis Oncology's Cash from Investing Activities rose 143487.50% to $11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.3 million, marking a year-over-year change of. This contributed to the annual value of $8.2 million for FY2024, which is 107.78% up from last year.
  • As of Q3 2025, Pyxis Oncology's Cash from Investing Activities stood at $11.5 million, which was down 25.05% from $15.3 million recorded in Q2 2025.
  • Over the past 5 years, Pyxis Oncology's Cash from Investing Activities peaked at $26.7 million during Q4 2024, and registered a low of -$18.5 million during Q1 2024.
  • In the last 2 years, Pyxis Oncology's Cash from Investing Activities had a median value of $11.5 million in 2025 and averaged $7.3 million.
  • Data for Pyxis Oncology's Cash from Investing Activities shows a peak YoY skyrocketed of 382,500.00% (in 2025) over the last 5 years.
  • Over the past 2 years, Pyxis Oncology's Cash from Investing Activities (Quarterly) stood at $26.7 million in 2024, then spiked by 143,487.50% to $11.5 million in 2025.
  • Its Cash from Investing Activities was $11.5 million in Q3 2025, compared to $15.3 million in Q2 2025 and $15.8 million in Q1 2025.